Reference ID: MET-8EC7 | Process Engineering Reference Sheets Calculation Guide
Introduction & Context
Solvent residue limits quantify how much extraction solvent remains in a finished product after drying or desolventisation. In process engineering these limits are critical for:
Regulatory compliance with agencies such as FDA, EFSA, and ICH.
Consumer safety, because many common industrial solvents (n-hexane, acetone, methanol, etc.) are toxic above trace levels.
Process optimisation—knowing the residual level guides dryer residence time, temperature, and vacuum set-points.
The calculation is routinely embedded in:
Batch release protocols for edible oils, pharmaceuticals, and botanical extracts.
HAZOP studies that link solvent inventory to potential worker exposure.
Environmental impact statements that convert ppm residues into kg solvent emitted per tonne product.
Methodology & Formulas
All quantities are expressed on a mass basis. The residue concentration \(C\) in parts-per-million by mass is:
\[ C = \frac{m_{\text{solvent}}}{m_{\text{product}}} \times 10^{6} \]
where
\(m_{\text{solvent}}\) is the solvent mass in the same units as \(m_{\text{product}}\) (kg in the code).
\(m_{\text{product}}\) is the total product mass (kg).
Conversion from milligrams to kilograms is handled by:
The computed residue is compared against a specification limit \(L\) (ppm). Acceptability is determined by:
\[ \text{Status} = \begin{cases}
\text{PASS} & \text{if } C \le L \\
\text{FAIL} & \text{if } C > L
\end{cases} \]
Parameter
Symbol
Unit
Constraint
Product mass
\(m_{\text{product}}\)
kg
\(m_{\text{product}} > 0\)
Solvent mass
\(m_{\text{solvent}}\)
mg
\(m_{\text{solvent}} \ge 0\)
Residue concentration
\(C\)
ppm
\(C \le L\)
Limit
\(L\)
ppm
Regulatory threshold (e.g., 1 ppm for n-hexane)
Start with the product’s daily dose and patient body weight to derive the permitted daily exposure (PDE) in mg/day. Divide the PDE by the maximum daily dose of the product (in g or mL) to obtain the concentration limit in ppm. Document the toxicological data, route of administration, and safety factors used so that reviewers can reproduce the calculation.
Class 1 solvents (benzene, carbon tetrachloride, 1,2-dichloroethane, 1,1-dichloroethene, 1,1,1-trichloroethane) are banned or tightly restricted; test for them whenever there is any risk of cross-contamination or supplier solvent reuse.
Class 2 solvents with low limits (e.g., acetonitrile, chloroform, methanol) must be tested if the process train shares equipment with other products that use them.
Any solvent flagged in the site-wide solvent map as “high carry-over potential” must be added to the routine monitoring panel.
Develop a scientifically justified skip-testing protocol: show three consecutive commercial-scale batches with results below 10 % of the limit using a validated analytical method.
Include a risk assessment that covers raw-material solvent grades, equipment cleaning verification, and environmental controls.
File the protocol in the site change-control system; re-qualify the skip frequency annually or after any process change that could re-introduce the solvent.
Obtain or generate toxicological data (NOAEL, LOAEL, carcinogenicity, genotoxicity) and establish a PDE using the same methodology as ICH Q3C.
Apply a route-specific adjustment factor (oral vs. inhalation vs. parenteral) and document the rationale in the regulatory filing.
Propose an interim limit in ppm based on the lowest feasible level your process can achieve (ALARP) and commit to update the limit once sufficient commercial data are available.
Worked Example: Verifying Solvent Residue in a 25 kg Batch of API
A pharmaceutical plant has just completed a methanol-wash step on 25 kg of an active pharmaceutical ingredient (API). Analytical testing shows that 20 mg of methanol remains in the dried product. The site specification limits methanol to 1 ppm. Does this batch meet the requirement?
